Form 6-K GLAXOSMITHKLINE PLC For: Jul 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GlaxoSmithKline (GSK) Tops Q2 EPS Views
July 29, 2015 7:01 AM EDTGlaxoSmithKline (NYSE: GSK) reported Q2 EPS of 17.3 pence, compared with the analyst estimate of 16.7 pence. Revenue for the quarter came in at £5.89 billion versus the consensus estimate of £5.87 billion.
Sir Andrew Witty, Chief Executive Officer, GSK said:
This is our first full quarter of performance since completion of the transaction... More
